Intelligence · Drug directory
Withdrawn Drug Applications
Drugs with withdrawn or discontinued regulatory applications in the US or EU — useful for competitive and label-history research.
Quick answer
Withdrawn applications: NovaPharmaNews tracks 229 pharmaceutical drugs in this segment. Drugs with withdrawn or discontinued regulatory applications in the US or EU — useful for competitive and label-history research.
-
tesamorelin
EGRIFTA
-
thrombin alfa
RECOTHROM
-
tilmanocept
LYMPHOSEEK
V09IA09 -
tixagevimab
EVUSHELD
-
trastuzumab duocarmazine
JIVADCO
-
trenonacog alfa
IXINITY
B02BD12 -
troriluzole
DAZLUMA
N07XX -
trovafloxacin
TURVEL
J01MA13 -
ulipristal
ESMYA
G03XB02 -
vorapaxar
ZONTIVITY
B01 -
vosaroxin
QINPREZO
L01 -
votumumab
HUMASPECT
V09IX -
ximelagatran
XIMELAGATRAN 36 MG FILM COATED TABLETS
Frequently asked questions
How many withdrawn drugs are listed?
229 drug profiles match this regulatory segment in our published index.
Where does approval data come from?
Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.